Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience

BACKGROUND: Olanzapine treatment prevents chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). However, its role in the secondary prevention of breakthrough CINV in real-world cancer care should be further evaluated. METHOD: We conducted a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiike, Akihiro, Kono, Haruka, Miura, Katsuhiro, Hayama, Tatsuya, Tsutsumi, Daisuke, Tsuboi, Shinya, Ohtsuka, Susumu, Hidaka, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391758/
https://www.ncbi.nlm.nih.gov/pubmed/37525281
http://dx.doi.org/10.1186/s40780-023-00293-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391758/
https://www.ncbi.nlm.nih.gov/pubmed/37525281
http://dx.doi.org/10.1186/s40780-023-00293-y

Ejemplares similares